Good morning, ladies and gentlemen. This is the operator speaking. Welcome to NN Group's Analyst Conference Call on its 4th Quarter 2016 Results. The telephone lines will be in listen only mode during the company's presentation. The lines Officer of NN Group, let me first give the following statement on behalf of the company.
Today's comments may include forward looking statements, such as statements regarding future developments in NN Group's business, expectations for its future financial performance and any statement not involving an historical fact. Actual results may differ materially from those projected in any forward looking statement. Any forward looking statements speak only as of the date they are made, and NN Group assumes no obligation to publicly update or revise any forward looking statements, whether as a result of new information or for any other reason. Furthermore, nothing in today's comments constitutes an offer to sell or a solicitation of an offer to buy any securities. Good morning, Mr.
Vriese. Over to you.
Hello, everybody, and thank you, operator. I will start off today's presentation by looking at the highlights of the 4th quarter results, the major events of past year as well as the progress we are making to deliver on our strategic targets. Delfin Rueda, our Chief Financial Officer will then talk you through the financial details of the results at group level and for the individual operating segments as well as our capital position. I will conclude the presentation with a wrap up, after which we will open the call for Q and A. We also have Jan Hendrik Erasmus, our Chief Risk Officer with us to answer your questions.
So let's turn to the slide of the highlights. Slide number 3. NN Group's operating result of the ongoing business for the Q4 of 2016 was €282,000,000 This is an increase of 13% compared with the same quarter of 2015 with most segments reporting higher earnings. On balance, the Netherlands units achieved further cost savings in the 4th quarter, bringing the expense base down to €761,000,000 Our insurance businesses reported a 12% increase in total new sales at constant currencies compared with the Q4 of 2015. This was mainly driven by the successful launch of new products.
The value of new business increased 6% on a full year basis despite lower interest rates. It was another strong quarter for NN Bank with significant production of new mortgages and healthy inflows of savings. And our asset manager and an investment partners again attracted net inflows of 3rd party assets. We continue to see volatility in the results of our Non Life business and this means that we are not yet making sufficient progress to lower our combined ratio towards our target. We continue to implement a range of measures with the aim of turning this around.
Our balance sheet and capital position remains strong. Free cash flow to the holding company was €154,000,000 in the 4th quarter, driven by €370,000,000 of dividends from our subsidiaries. This brought the cash capital at the holding to €2,500,000,000 at the end of the 4th quarter. The Solva C2 ratio of NN Group increased to 2 41%, mainly due to favorable market movements. Please note that the reversal of the suspended buyback program and the deduction of the proposed 2016 final dividend are both reflected in this ratio.
This robust position allows us to propose a final dividend for 2016 of €0.95 per share, bringing the 2016 full year dividend to €1.55 per share. I will now turn to Slide number 4. NN Group aims to help people secure their financial futures while delivering an excellent customer experience based on transparent products and services and long term relationships. We do this by investing in new and improved products and by innovating our customer experience. Let me give you some examples.
Our Dutch pension business has introduced new features to its product proposition, including the option which allows customers to increase their individual savings within defined contribution products. And in Romania, we have written over 10,000 new health policies since April, which was double our expectation. We continue to implement efficiency initiatives which benefit our customers. In the Netherlands, several new products were made available in the online portal called My NN and in the NN app. In Belgium, a home and family portal was created where customers are able to modify their insurance, request certificates or file a claim online.
And NMM Bank introduced a track and trace system for mortgage applications. Our strategy in the Netherlands is centered around providing digital, personal and relevant services. In previous quarters, I've mentioned the concept of next best actions, which are relevant services or products that we proactively offer during interactions with customers. These suggestions are highly valued by our customers. And in the Q4 of 2016, we included over 242,000 of these next best actions in our customer conversations, which is more than the whole of 2015.
We've also started to offer next best actions through the NN app and website and even via Facebook. So now let's turn to Slide number 5. 2016 was an eventful year for NN Group. In April, ING sold down its remaining stake in NN. And during the year, we executed several transactions as we regularly assess our portfolio of businesses.
In May, we acquired Nodus, a financial broker in Poland, increasing our distribution strength in that country. In July, we sold Mondelez Partners, one of our wholly owned independent insurance brokers. And in October, we announced the transfer of our Irish reinsurance portfolio. We've always said that we would consider M and A where we believe that we are the right owner of the business and if it creates more value than the alternative of returning cash to shareholders. We initially announced our intended offer for the ordinary shares of Delta Lloyd in October 2016.
Since then, we have reached an agreement on a recommended transaction that is supported by the boards of Delta Lloyd. I will talk more about this transaction in the next slide. And finally, in January 2017, NN successfully issued €500,000,000 in senior unsecured debt and €850,000,000 in subordinated debt. The proceeds of the subordinated debt have been used to fully repay the outstanding hybrid loans with ING Group. So let's turn to Slide number 6.
On the 23rd December 2016, we announced that we have reached an agreement on a recommended all cash public offer of €5.40 per share for all issued and outstanding ordinary shares of Delta Lloyd. This represents a total consideration of €2,500,000,000 We are pleased that this offer has the support and recommendation of both the Executive Board and the Supervisory Board of Delta Lloyd. The combination of NN Group and Delta Lloyd will allow us to strengthen our positions in the Netherlands and Belgium. Customers of both companies will benefit from an enhanced proposition as a result of the complementary product offering and distribution as well as further improvements in customer service and experience. The combined group will be better placed to capture opportunities that technological innovation brings and will provide increased possibilities for knowledge sharing and strengthening capabilities and talent development.
It will bring a perspective of growth and lead to opportunities for employees of both companies. We also anticipate that we can achieve meaningful cost and capital synergies and expect a double digit increase in the dividend per share for 2018 and onwards. All in all, we strongly believe this transaction to be in the interest of the stakeholders of both companies. The offer period commenced on 3rd February and will run to the 7th April. This means that the transaction will likely be completed in the Q2 of 2017.
We will of course update the market as required in the coming months. So let me move on to our financial targets on Slide number 7. So let's look at how we're delivering on the financial targets that we have set for Enen Group as a whole. Firstly, we aim to realize an annual growth rate of the operating result before tax of the ongoing business of 5% to 7% on average in the medium term. Measuring this for the period 2013 to 2016, we have achieved a compound annual growth rate of 11%.
I've already mentioned that the current administrative expense base of our Netherlands units, which are Netherlands Life, Netherlands Non Life and the holding entities, is €761,000,000 We have actually reduced this expense base by almost 25% since 2013, and we are well on our way to reaching our current target of €685,000,000 by the end of 2018. We expected to achieve 30% of the targeted cost savings by the end of 2016, but the savings to date are in fact ahead of that. Thirdly, we aim to increase the net operating return on equity of the ongoing business in the medium term compared with the 7.1% in 2013 and have reported 8.1% for 2016. Aligned with these three targets, we expect over time to generate free cash available to shareholders in a range around the net operating result of the ongoing business. In 2014, free cash flow adjusted for the IPO related items was lower than the net operating results, while in both 2015 2016, the free cash flow exceeded the net operating result.
Taking these 3 years together, we generated total free cash flow of €3,200,000,000 and a total net operating result of €2,900,000,000 so in line with our target. Delfin Rueda, our CFO, will go into the details of our free cash flow later in the presentation. So let's turn to Slide 8. As I mentioned earlier, we have today announced that we will be proposing a 2016 final dividend of €0.95 per share, bringing the total 2016 dividend to €1.55 This represents a payout ratio of around 51 percent of the net operating result of the ongoing business, which is slightly above our envisaged 40% to 50 percent payout ratio in our dividend policy. It is also in line with our aim to pay sustainable and predictable dividends.
The proposed dividend will be voted on at our Annual General Meeting of Shareholders in June. In total, NN Group has returned more than €2,100,000,000 to shareholders in the form of dividends and share buybacks since the IPO 2 years ago, including the proposed 2016 final dividend announced today. This demonstrates our commitment to return excess capital to shareholders unless we can better deploy it in other value creating corporate opportunities. And with that, I will now hand over to Delfin Rueda. Delfin?
Thank you, Lard. Let me start by presenting the 2016 full year results. NN Group reported an operating result of the ongoing business of €1,200,000,000 for 2016, down 14% on 2015. To understand this decrease, we need to take into account that the operating result for 2015 benefited from higher private equity dividends of €221,000,000 compared with €72,000,000 in 2016. In addition, the 2015 full year operating result reflects a significantly higher technical margin in Netherlands Life, while 2016 was impacted negatively by €31,000,000 of claims in Netherlands Non Life as a result of severe storms.
The 2016 full year operating result benefited from lower administrative expenses in the Netherlands and a higher result at NN Bank. Looking at the bottom line, you can see that the 2016 full year net result decreased 24% compared with the previous year. This largely reflects the lower operating result that I have just explained. A higher negative hedge result in Japan Closed Block VA due to increased market volatility and a negative result on divestments, partly compensated by higher non operating items. The result on divestments include the loss on the transfer of our insurance portfolio in Ireland to Canada Life and a provision that we set following the outcome of arbitration proceedings in respect of NN Group's former insurance company in Korea.
Both of these items were recognized in the last quarter of the year. Please now turn to Slide 11, which gives more details about the expense savings in the Netherlands. As you know, in November 2015, we set ourselves a new cost target in the Netherlands, which aims to reduce the annual administrative expenses of Netherlands Life, Netherlands Non Life and the holding entities to €685,000,000 by the end of 2018. With this target, we aim to reduce expenses by around 15% compared with the annualized cost base at the end of the Q3 of 2015. This expense reduction program is well on track.
Since the start of the program, we have achieved total cost savings of €57,000,000 which represents 43% of the total targeted expense reductions. As Lard already mentioned, this is ahead of the 30% that we expected to achieve by the end of 2016. We will continue to work hard to implement a range of cost containment measures to deal with upward cost pressures as well as investments in the business and to reach this ambition expense base target as planned. Let's now look at the 4th quarter performance of each individual segment. And as usual, let's start with Netherlands Life in Slide 12.
The operating result of Netherlands Life was €163,000,000 in the Q4 of 2016. The 5% increase compared with the same period of 2015 was by a higher investment margin. We continue to focus on increasing the allocation to higher yielding assets and this helped to offset the impact of the low interest rate environment on reinvestments. The last 12 months' investment spread was 116 basis points. This is lower than 2015, which benefited from higher private equity dividends.
However, it remains above the 2013 level of 104 basis points, which we indicated that we would work to sustain. I would now turn to Slide 13 for the results of Netherlands Non Life. The operating result for Netherlands Non Life decreased to €13,000,000 from €28,000,000 in the Q4 of 2015. As you are aware, the result of these segments can be quite volatile depending on the size and frequency of claims in any quarter. In the Q4 of 2016, we saw unfavorable underwriting performance in both disability and accident and property and casualty as well as higher administrative expenses and lower investment income.
The combined ratio for Non life as a whole increased to 104% from 101% in the Q4 of 2015. For a more detailed explanation of developments in the quarter, let's look at the 2 business lines within Non Life separately. In disability and accident, the operating result decreased to €11,000,000 from €21,000,000 in the Q4 of 20 15. This was due to an unfavorable claims experienced in the individual disability portfolio, which was partly compensated by favorable claims experienced in the group income protection portfolio. The D and A combined ratio was higher at 105% compared with 101% in the Q4 of 2015.
However, if we look through the quarterly volatility at the combined ratio for the full year 2016, this was 98%, which is broadly in line with previous years. The operating result in property and casualty was 0 compared with EUR 6,000,000 in the Q4 of 2015. This decrease reflects an unfavorable claims experience in the motor and miscellaneous portfolios, partly compensated by a favorable claims experience in fire. The P and C combined ratio increased to 103% from 101% in the Q4 of 2015. The full year 2016 combined ratio for property and casualty was 108%, including the impact of the severe summer storms.
Turning to Slide 14, we'll see the Insurance Europe results. The segment Insurance Europe reported an operating result of €60,000,000 for the Q4 of 2016. This was 25% higher compared with the same quarter of 2015 as a higher technical merger and higher fees and premium based revenues were partly offset by higher administrative expenses. New sales increased to €138,000,000 in the Q4 of 2016, up 7.8% from the Q4 of 2015 at constant currencies. This was mainly driven by higher life sales in Poland and higher sales of less capital intensive savings products in Greece.
The value of new business for the full year 2016 decreased to €85,000,000 from €96,000,000 in 2015. This was mainly due to lower interest rates and the impact of the tax on assets in Poland, which was introduced in early 2016. Moving now to Japan Life on Slide 15. The operating result of Japan Life was down 20% from the Q4 of 2015, if you exclude currency effects. The reason for this decrease is a lower technical margin and higher DAC amortization and trade commissions, which was partly offset by higher fees and premium based revenues.
New sales in these segments increased to EUR 144,000,000 up almost 23% from the Q4 of 2015 and at constant currencies. This reflects higher protection sales and sales of the COLI critical illness product, which was
launched in July 2016. The value of
new business for 2016 The value of new business for 2016 increased to EUR 121,000,000 up 8% from 2015, excluding currency effects. This increase came from higher sales and a shift to a more profitable product mix, which more than offset the impact of lower interest rates. Now let's turn to asset management. Total assets under management decreased to €195,000,000,000 from €199,000,000,000 at the end of the Q3 of 2016. The decrease reflects a negative market performance of €6,000,000,000 mainly as a result of higher long term interest rates, which reduced the value of fixed income assets.
This was partly offset by net inflows of assets on more than EUR 1,000,000,000 primarily in third party mandates. The operating result of this segment increased to EUR 33,000,000 from €21,000,000 in the Q4 of 2015. Let me remind you that last year's result including a €13,000,000 restructuring provision. In terms of income, fees were up slightly in the Q4 of 2016, reflecting higher average assets under management and despite the continuing shift towards lower margin assets. The cost income ratio improved on higher fee income and lower administrative expenses.
And finally, our last segment other in slide 17. The operating result of the segment other improved to a loss of €10,000,000 in the Q4 of 2016 from a loss of €29,000,000 in the same quarter of 2015. The main components of these segments are the holding result, the reinsurance business and NN Bank. So I will now look at this in turn. The holding result improved to a loss of €27,000,000 mainly driven by lower holding expenses.
The operating result of the reinsurance business improved to a loss of €1,000,000 from a loss of €7,000,000 in the same quarter of 2015, which was impacted by lower underwriting results. Finally, the operating result of NN Bank increased to EUR 16,000,000 in the 4th quarter, up 49% year on year. This reflects a higher interest margin in favorable other income, partly offset by higher expenses to support the bank's continued growth, including an €8,000,000 restructuring provision. I will now move to on the slide to cover our last segment, Japan Closed Block VA. Japan Closed Block VA reported a result before tax of €11,000,000 compared with €24,000,000 in the Q4 of 2015.
The lower hedge related losses in the quarter were offset by a reserve increase due to lower lapse assumptions on debt benefit policies. The Q4 of 2016 also reflects lower fees and premium based revenues as the portfolio continues to run off. And that completes the results of our operating segments. On the following slides, I would like to take you through the free cash flow and the capital position. On Slide 19, we show the movement in the holding company cash capital during the Q4 as well as for the full year 2016.
The holding company cash capital position increased to EUR 2,500,000,000 at the end of 2016. The free cash flow during the Q4 was €144,000,000 which included dividends of €370,000,000 received from subsidiaries in the Netherlands and Ireland, partly offset by capital injections, mainly into Greece and NN Bank. Details of the dividends upstreams per segment can be found in the appendix to this presentation. The free cash flow during the full year was more than EUR 1,300,000,000 driven by dividends received from all business segments. This was partly offset by EUR 812,000,000 of capital flows to shareholders, which consist of cash dividend payments and the share buybacks executed during the year.
On the next two slides, I would like to talk you through the developments in NN Group Solvency II ratio. On Slide 20, we show the movement of the NN Group Solvency II ratio, the legible own funds and the solvency capital requirement during the Q4 of 2016. In the quarter, the Solvency II ratio increased from 2 36 percent to 2 41%, mainly driven by market variances, along with some contribution from operating return. This was partly offset by the impact of eligibility constraints and changes in non available owned funds. Now let me explain the movement in a bit more detail.
Starting with the largest movement, market variances, which had a positive impact on the solvency ratio of 7 percentage points. This mainly reflects the impact of higher interest rates as well as positive equity and real estate revaluations, partly offset by a steepening of the yield curve. The operating return had a positive impact of 3 percentage points. This quarter, the operating return includes some negative impact from experienced variances. As I have highlighted in the past, the operating return will move around quarter by quarter.
The bucket other reflects a negative impact from eligibility constraints due to a lower SCR and as a consequence, a lower Tier 3 cap. It also reflects an increase in non available on funds as well as the provision for ING Life Korea. Capital flows reflect both the reversal of the €333,000,000 deduction of the suspended share buyback program and the proposed 2016 final dividend of €307,000,000 The SCR decreased mainly driven by an increase in interest rates in the quarter. So that explains the movement in the 4th quarter. On the next slide, we will look at the development of the Solvency II ratio over the full year 2016.
The Solvency II ratio of NN Group increased from 2 39% to 2 49 2 41% in 2016. This mainly reflects the positive impact of the operating return of 19 percentage points, offset by capital flows to shareholders of €919,000,000 which had an impact of 17 percentage points. Capital flows include the proposed 2016 final dividend of €307,000,000 The operating return in 2016 was approximately €900,000,000 but includes a couple of lumpy items. These were the full year 2015 net result of asset management of approximately €80,000,000 the nonrecurring benefits in Japan Life of approximately €50,000,000 and the impact of the transfers from the separate account to the general account of approximately €100,000,000 in the Q1 of 2016. The SCR in the operating return shows a release of approximately €100,000,000 on a full year basis, reflecting the runoff of portfolios, partly offset by the new business we sold.
Note that market variance led to material volatility during the year, but was actually small on a full year basis. And with that, I will pass you back to Lard for the wrap up. Thank you, Delfin.
Before wrapping up this presentation, let mention the announcement that we made this morning that Stan Beggers, our CEO of NN Investment Partners, will retire on the 1st April of 2017. I would like to take this opportunity to thank Stan for his contribution to NN Group over the past years. And I'm pleased that we have found a strong successor for Sten within our own senior management team. Satish Bapat, currently our CEO in Japan and with extensive experience in our asset management, will succeed Stan as CEO of Investment Partners and as a member of our management board. I will now round this presentation by saying that we are pleased with the results that we have presented for the Q4 and the full year of 2016.
Our expense reduction program is progressing well. We remain fully focused on further improving the operating performance of the businesses and are aware that we still have more work to do to achieve all the targets we have set ourselves. We believe that it is essential to maintain a strong balance sheet at all times. Our capital position remains robust, and this allows us to take an important step in bringing consolidation to the Dutch Insurance and Asset Management Markets. It also allows us to keep delivering on our promise to return capital to shareholders by proposing a final 2016 dividend of €0.95 per ordinary share.
We look forward to successfully completing the transaction with Delta Lloyd in the Q2 of 2017. We recognize that combining our businesses will require significant effort from all of us, but it will also lead to enhanced opportunities. At the core of all future developments is our ambition to help our customers to secure their financial futures and to deliver an excellent customer experience and to be a company that truly matters in the lives of our stakeholders. I would now like to open the call for your questions. And as always as I always do, can I kindly request you to limit the number of your questions to 2 per person so that everybody gets a chance to speak?
And of course, feel free to come back with a second round of questions if they have not yet been dealt with. With that, operator, I'm handing back to you for Q and A.
Thank you, Mr. Vriese. Ladies and gentlemen, we will start the question and answer session. The first question is coming from Mr. Cor Klas, ABN AMRO.
Go ahead please, sir. Good morning. Cor Kluis, ABN AMRO.
I've got a few questions. First of all, about the eligible funds on Slide 20. You showed there that the market variance was EUR 500,000,000 negative in the quarter. Could you elaborate on that what exactly the pieces were in that because equity markets were doing well, interest rates went up. Why was this?
Was this mostly driven due to a steepening of the yield curve? Because you showed that the steepening effect was higher than in the past in the sensitivity analysis, at least a split of that one? And second question is about the Solvency ratio at this moment. A lot happened, of course, in the Q1. So rates went up, got espresso and coffee went up, steepening was more.
Could you give an indication what the Solvency II ratio would be at this moment? It's probably going to be lower than 2.40% or 41%.
Those are my questions.
Thank you, Cor. Good morning. I will hand that to Jan Hendrik Erasmus, our Chief Risk Officer. Hi,
Cor. Thank you a lot for the question. And Cor, yes, the first thing is to note is that interest rates went up in the quarter. So what we saw is that, course, our solvency capital requirement came down during the quarter. And Solvency II has a rule that your Tier 3 capital cannot be more than 15% of your solvency capital requirement.
So as that number comes down, so your Tier 3 capacity also comes down, and that's what you see in that effect is that we have some deferred tax assets, which are they still have economic value, but under Solvency II, we don't get value for them. Together with that, there was a small impact of some non available owned funds, which resulted from an injection we put into a unit that is now considered to be not fungible. On the second question, the ratio for the year to date, I think we have had some headwinds. You can see them yourselves in the markets. We disclosed some sensitivities to government bond spreads, and those have continued to widen for some of the high quality sovereigns in Europe.
So we expect that it's a little bit lower than the year end number.
Okay,
very clear. Thanks.
The next question is from Mr. Faquan Morelli. Go ahead please, sir.
Good morning, gentlemen. Just two questions, if I may. Firstly, the DNB has issued kind of new guidelines on the Lac DT. I just wondered if you could work through which elements of those you regard as new versus the prior guidance and what the implications are, if any, for NN Solvency II ratio? And more generally, when might we get confirmation from the DNB that this issue is settled?
Because obviously, I think the guidance talks towards the Q2 of 2017. And then secondly, just on the Solvency II sensitivity, could you just explain why the sovereign spread sensitivity has increased between the first half and year end. Does that reflect increased sovereign exposure? Or are there other dynamics going on there? Thanks.
Yes. Thank you, Farquhar. So the second question on the sensitivities will be answered by Jan Hendrik, but let's first do the LACTD question. So sorry, Delphica, you take that one.
Yes. Thank you, Farquhar. So indeed, I think it I mean, last Friday, there was a new guidance from DNB on the LAC DT. So we have taken that guidance very carefully into account. And our approach at year end 2016 is fully compliant with this guidance.
And I mean, trying to explain what had changed from this guidance to the previous one within the call will be, I think, quite messy. But I think that the important element to reinforce is that our LAC DT calculation in our full year 20 16 numbers is according to this guidance.
Henrik?
Thank you, Francois, for that question. Our sovereign exposures haven't significantly increased. We still remain comfortable with the high proportion of sovereigns as part of what we consider to be a relatively defensive asset portfolio. The increase in the sensitivity you see is primarily caused by the steering that I described earlier. Essentially, you get a loss absorbing effect if you don't hit your Tier 3 year cap.
And when you start hitting it, you'd get less loss absorbency from deferred tax assets that you would set up in those scenarios. So it's primarily caused by the Solvency II Tiering.
Next question from Mr. Michael van Wiegen, Bank of America. Go ahead please, sir.
Yes, good morning guys. Quick one or 2. First of all, can you indicate on a pro form a basis, including the target, the Delta Lloyd acquisition, what capital levels you feel comfortable with? Because I think you talked about a pro form a Solvency II ratio of low 190s or mid-190s at the Q3 stage. I think that how things are developing right now, that would be under further pressure.
So it will be good to understand where what capital levels you feel comfortable. And can you talk about an updated pro form a Solvency II ratio for with Delta Lloyd? Or is that, given Delta Lloyd hasn't reported numbers at this stage, not possible? Thank you.
Thanks, Michael. Delfin? Yes. Thank you, Michael. Yes, as you can imagine, without having the disclosure of Delta Lloyd coming next week will be prudent to comment on new pro form a ratios.
What we have I would highlight 2 things here. I mean, one is the very strong starting position of our solvency ratio, as has been mentioned before, has increased by 5 percentage points in the quarter. We are at 241%. And indeed, the pro form a as of September 2016 was in the mid 185 percent, including some expected adjustments as we flag it at that point of time. I believe that that level of solvency is obviously less generous that we have been used to, but still very comfortable going forward.
Does that answer your question?
Thank you.
The next question is from Mr. Arjan Van Veen, UBS.
Just two questions. The first one is on this reduction or the reduction in eligibility with reference to Tier 3. If I look at your group Tier 3 capital, it's gone up from 11% to 14%. The actual number has gone up, while the SCR has gone down. So doesn't look like this is the case at the group level, but maybe the constraint is kicking in at the Netherlands Solvency the Netherlands division.
So can you just clarify that? Secondly, on the P and C, it just doesn't seem to be getting better. It's like, say, 108 now in the P&C division. So just curious as to why it's not improving. Is there underlying trend deterioration?
And do you expect to get better in 2017?
Yes. Thanks, Arian.
Let me take the P and C question first, and then I will ask Jan Hendrik to comment on your eligibility question. On Non Life. Non Life results, as we all know, are volatile by nature. So I also want to remind everybody of the big storm that we all had in the Netherlands and may begin June. We also had large fires in 2015, and there is month to month some volatility that we've seen in disability.
But it's good to take, therefore, a view across the quarters first to look at the underlying trends. And if you see that is that overall and despite some quarterly volatility, our D and A book actually runs at a combined ratio of around 98% for the past 3 years. And this is quite healthy for a business that has a that is long tail. And please note that this was on the back of an improvement program because we turned around this block of business in the recent past and is, as I said, running with a meaningful operating result of more than €90,000,000 per annum and at a 98% combined. So that's the D and A business, a large piece of our non life company.
Then we have worked hard to improve the fire up business. And if you take out the storm effect, the underlying combined ratio is 95% on which the Fire Up business runs on 2016. We've reduced expenses, and we will continue to do so, but you saw the expense ratio also improve this year. And so the real underperformance in Non Life is driven by the Dutch motor book, and that's where we have taken action. And we will continue to take action by calling non profitable products and by repricing the book.
Now I note here though that it takes time for this to translate into better results, and I'll explain to you why. Number 1, there's a reality of a highly competitive marketplace, which hampers our ability to reprice as forcefully as we would like to. And we also are confronted now and then with adjustments on older claims that we need to settle over time. So please bear that in mind. Now moving forward, we will continue obviously with our progress with our work to improve the results, reducing expenses further, which is really needed in the motor book and also underwriting actions where needed to ensure that we work toward our combined ratio target.
Now with that, I would like to hand over to Jan Hendrik on the first question that you had, Arjen.
Thank you, Lard and Arjen for that question. Arjen, you're right, firstly to say that this impact was larger in the Life company than at group level, but we still saw a small impact at group level because the steering is actually based on the Solvency II internal model SCR, if you like, and that excludes the non Solvency II entities. So the 14% you see is not exactly the right number to compare it with. On the other hand, your insight is also correct.
Okay. Can I just ask
for lobsters? So if the DNB is stricter, you've already capped some of your LACT TT now, so is there any potential reduction you already partly reduced now effectively?
On LACCD, Delfin, you want to comment?
Yes. But I think as we're talking about different things, the LAC DT is assets that are impacting home funds.
I guess they're quite mutually exclusive.
Yes. Thank you.
Next question is Ashik Musaddi, JPMorgan. Go ahead please.
Hi, good morning everyone. So just one question with respect to the cash that you're streaming from subsidiaries. I mean, your guidance has been very clear. It should be roughly in line with the operating result. But for past couple of years, it's materially higher.
I mean, because it's materially higher. So what is driving that? And where do you think going forward will that be lower? Because I mean, Dutch Life continued to give a stable number, Dutch Non Life as well. Any thoughts on that?
Where do you think the cash release would be lower going forward? Thank you.
Thank you, Ashik. Adelphine, would you be so kind?
Yes. So obviously, in order to have amount of free cash flow generation on the range of the operating result, taking into account that there are also holding expenses and the cost of debt, you need to have a higher increase, a higher dividends coming from the subsidiaries in order to maintain that. So I think we have seen over the last couple of years a very strong flow of dividends from subsidiaries. That was also the case in this quarter. And I think important to mention that, that was achieved without deteriorating the level of solvency in these entities.
And that, of course, is a critical element when looking at our level of solvency and the ability to generate capital going forward.
Thank you. And just one more follow-up question on the sovereign spreads. I mean, sovereign spread is kind of widening at the moment, but it's still relatively tighter. I mean, is there any way you're thinking about locking those sovereign spread? Or virtually, it's very difficult and maybe uneconomic as well-to-do
that? Yes. Thanks, Ashik. So Jan Hendrik?
Hi. Thank you, Ashik, for that question. The sensitivity we disclose is, of course, to all sovereign spreads moving in parallel by 50 basis points at the same time, which is a relatively big shift. And we also need to think about the underlying economics, which is that we think we're more exposed to default risk there than spread risk. Spread risk, of course, affects the timing of your capital generation, but the real underlying risk is default risk.
Of course, we are considering many options. One of them is spread locks, and we tend to do these things when it makes sense to do them rather than to be forced into them.
And at the moment, you don't think it's necessary to lock it?
It's one of the options we're considering. But as I have explained before, I think our solvency position is very strong at the moment. So we will only do it when it makes sense.
Okay. Thank you.
Next question is Mr. Benoit Petrarque, Kepler. Go ahead please.
Yes. Good morning. A few well, one question with on the capital generation and then over on Non Life. First of all, on the on fund generation, €100,000,000 rounded figure. Could you maybe provide a bit of granularity in terms of how much it is in millions and also the impact of the experience variances this quarter?
I think over time, variances should be close to 0. So I was wondering if you were more close kind of to EUR 150,000,000 this quarter on a clean basis or closer to EUR 100,000,000? And also maybe on the SCR for the full year 2016, How much is coming from NN Life versus Japan VA? Could you also give us a bit more details on that? And then on Non Life, I was wondering if the visibility volatility is kind of a trend now.
I mean, it's combined ratio is up this quarter. Are you expecting a slightly higher combined ratio in the coming quarters as well? Or it's just volatility in the quarter? And I saw unpremiums up 9% in Q4 versus Q4 2015. Is that the kind of first sign of the repricing we've been talking about?
Benoit, I didn't catch your last question, but first on the D and A volatility, so maybe you want to repeat that. But first on the D and A volatility, that's really volatility in the quarter. So that's it. And again, over the we've seen some volatility during the quarters, but overall it's 98% combined. I think what's your last so your last question
on the Yes, the
last question was on if you look at the non life business, earned premiums were up 8.5% in Q4 'sixteen versus Q4 'fifteen. This is quite nice increase of premiums. Is that fully repricing, which is starting to be visible now?
It's nothing special. So that's but it's partly that plus some growth in some fire business, etcetera. So I wouldn't there's nothing special in that particular line. Let me go to the operating return question that you had. So Delfin, would you be able to
take a quick one? Yes. Benoit. So in terms of the operating return in the quarter, as I mentioned in previous quarters, this is influenced by quite a number of factors. In the full year, as you saw, we had the operating return of approximately EUR 900,000,000 in the Own Funds and a release of approximately €100,000,000 during the year.
And obviously, when you look at larger period of time, this is the 1st year that we're reporting capital generation under Solvency II. I mean, that gives a better indication of how things move. During this quarter, we witnessed some negative experience, as I said before, some negative experience variances in Life and Non Life. And this can move around from quarter to quarter. In addition, in the first in the last quarter of the year, we saw strong sales in Japan, which reduced the capital generation due to the initial new business strain.
In terms of how to split the SCR from Life and the Japan Closed Block VA runoff, I mean, the Japan Closed Block VA runoff, you have seen the indications that we have provided. We still have EUR 400,000,000 that is expected to be free up up to 2019. And keep in mind that also in the movement of the SCR, there is the contribution or the drag due to new business.
Okay. Thank you.
The next question is from Mr. Gordon Aitken, RBC. Go ahead please.
Good morning. A couple of questions, please. First, on costs. I mean, the headcount is essentially unchanged over 2016. Usually, a large component of cost basis of insurance companies are staff.
And even if you weren't making any redundancies, I expect you still could reduce the headcount by not hiring the replacements for those that leave. So if you could explain that one, please? And secondly, on the Dutch buyout market, it's been very quiet for years now, and you've been Russell was even less than quiet. I'm not doing very much, but essentially, you're taking on a huge number of DB schemes with the Delta acquisition. So what's the outlook for this market and your participation in it, please?
Thank you.
Yes. So Gordon, first on the second piece, which is the Dutch buyout market. We've always maintained the view that we only write this business if it meets our pricing requirements. We have done a large transaction last year actually, €420,000,000 I believe by heart, which did meet our requirements. But if it don't, then it doesn't.
So we're just taking a rational approach to that and we will continue to do that in the future as well. In the outlook for the market, the Netherlands is very much that defined benefit will move to defined contribution. That is a trend, obviously, very much influenced by the low interest rate environment and longevity and the affordability of those plans for employers. So what you see happening is that the renewals that take place are largely renewals that become defined contribution plans. Now please note that this is new money, so for the new period for the new periods.
And therefore, the stock on your balance sheet will come down as these contracts migrate to, let's say, defined contribution, but that takes time. So it will be a gradual move because the in stock of the past is, of course, on your balance sheet, while the new money is something that you can that is usually contracted on a defined contribution basis. If we then go to the first point about expense reduction, well, first of all, I think we're making good progress there. If I look at what we've done over the last years since we entered into this journey, we took 25% out of the cost base in the Netherlands in scope areas. Secondly, we're progressing ahead of what of our guidance when it comes to the additional expense reduction plan.
So we're actually quite pleased with the way the company is on its road to reduce expenses. Now please note, this is not only about headcount. Headcount indeed is a large piece of the expense base, but it also a lot to do with technology. So we're doing a lot in changes in technology, leases, re procurement of networks, data server consolidation, all these things. And also these things contribute, including square meter usage in locations and the like.
So there's many things that contribute to the expense reduction program. The FTEs, please note that you're looking probably at the aggregated number, which means that Japan and Europe are up actually in FTEs since they have a growth and that that's where we hire people. So that's one thing. And the other one we also do as part of the expense reductions, by the way, is that we have externals that are sometimes more expensive than hiring on a full time basis. And on a selected basis, we also move externals that are actually more permanent into permanent contracts because that is better in terms of financially.
So that's why.
Yes. Thanks very much.
The next question is from Mr. William Hawkins, KBW.
Delfin, when you were talking about the one offs in the operating capital generation on Slide 21, you referred to that €100,000,000 of shift from SA to GA. When that happened in the Q1, you were saying that was seasonal rather than explicitly one off. So can I just confirm that, that is seasonal and we should be expecting another similar figure in the Q1 of 'seventeen? And then secondly, in your prepared remarks, you didn't make reference to morbidity weakness in the Dutch Life result that offset the benefit of higher yields. Forgive me if this has come up before, but I'm really not even sure what the morbidity issue would be in your Dutch Life portfolio.
So very briefly, can you just say what is the issue? And can we be sure this is just a one off? Or is there something that needs to be addressed in the future?
Thanks, William. So Delfin?
Thanks, William. Yes, indeed, the shift from the separate account to the general accounts tends to happen, most of it within the Q1. That doesn't mean that there could be small transfers during the rest of the year. But also for 2017, we would expect the same thing happening in the Q1 of 2017. Obviously, as this separate account is becoming smaller, this will be a time which is getting closer on which there won't be further changes.
So this volatility in the operating return will eventually go away. In terms of the morbidity results, which were quite negative in the quarter for Netherlands Life, just maybe to explain what it is. I mean, this relates to cases of disability on which the pension hold pension clients, when they became disabled, we cover their pension premium ourselves. But this is something that can be can occur, can be volatile. But basically, that impact in the quarter did not only reflect the movement in the quarter, so there was some part of it related to previous periods.
So there was a bit of a catch up in recognizing that morbidity weaknesses. So I would not consider that as a recurrent item.
Thank you, guys.
The next question is from Matthias David, KBC Securities. Go ahead please. Yes, good morning. Thank you. Just to come back on the operating
return, you referred to the negative impact of the growth in the Japanese business. Could you quantify that product strain impact both on a quarterly and a full year basis, please? And also linked to the operating return, we've seen, yes, increasing interest rates recently, some spread movements. So just wonder whether you could say anything on how this impacts your capital generation going forward. So I think in the past, you gave for interest rates, you have hard drag.
So maybe you could update us on that number as well, please. And then secondly, just to come back on Cor's question on the €500,000,000 negative market for Ryan's impact in owned funds. I'm not sure if I understood the answer, but I think it could be helpful if you could break that down between the rate spreads and equities because I was also expecting a less negative or even small positive for that number. So maybe there is some non economic items as well you could highlight. Thanks.
Yes. So let's Mattias, thank you very much. Let's start Jan Hendrik with the negative market variances on all funds and then Delfin will take the other components of your question.
Hi, Matthias. Thank you for the question. I mean the negative market variance on Own Funds is primarily from rising interest rates. I think we have to go back to how we do our asset liability management. We have said in the past that we don't hedge the UFR or the risk margin.
We try to match asset cash flows with liability cash flows. And that means under the Solvency II framework that you see that when rates go up, our own funds will go down, and that's what we have seen. So pretty much as expected.
And if you would look at it on an economic basis without UFR, would it I guess you would have shown a positive number there? Or
Well, I think on an economic basis, it's pretty much a better match, right? So we're trying to match it closely on an economic basis or on a cash flow basis.
Okay.
Yes, Matias. So on the impact on the operating return from Japan, I think it's important to understand that as Japan is not a Solvency II entity, the dividends and the capital generation are driven by the Japanese GAAP profits. And a consequence, due to the initial acquisition cost, sales in Japan results into Japanese GAAP profit strain as the is not recognized the deferred acquisition cost in the same way that we do under IFRS. However, obviously, over time, these sales will result in growing in force profits and as a consequence, higher capital generation. So that is why when Japan increases the sales, it depres somehow the capital generation.
We have not specifically quantified that amount. I'm not sure if there was another question. I think there was how does the impact the capital generation going forward? Yes, yes, yes, yes. I remember now the question.
So it's about in the operating result, how the higher interest rates will impact capital generation. And certainly, with higher interest rates and higher spreads, we have a negative impact on Own Funds. But as we explained in the past, that result into higher capital generation going forward. And I think, as you know, it's related to different aspects, but I think that's the key message to take away. We should not be quantifying it from 1 quarter to another.
Okay. Thanks a lot.
Next question, Mr. Bart Horsten, Kempen and Co. Go ahead please, sir.
Yes. Good morning. Thank you for taking my questions. As a follow-up on Japan Life, well, it seems you're doing all the right things if you look to the growth. And you just said, okay, through the initial cost, it not filters through in the IFRS results.
When do you think that we can see the impact on that from higher free cash flow coming or dividends coming out of Japan? That's my first question. The second question relates to, more in general, the sensitivity of your sensitivities. It appears pretty volatile, and I was wondering whether that was all related to the lack of headroom in the Tier 3 part or are there other reasons for that? And if I may, one final question is we've seen some news flow recently on some unit linked claims after a relatively longer period of silence.
And I was wondering if you experienced the same? Or is there anything out of from and then on this topic, which you could highlight on that? Thank you.
Thank you very much, Bart. Let me start with the last question that you had about the unit linked claims. There was some news flow indeed recently on a couple of rulings visavis other participants in the industry. When it comes to ourselves, there is nothing to update you on today. There are however, it may be good to remind you that there are obviously pending cases, and they may come to rulings in the course of this year.
So that's that one. Then on sensitivities, of your sensitivities. So Jan Hendrik. And then the first question will be done by Delfin Bart. Okay.
Thank you, Bart. Yes, I mean the last time we disclosed sensitivities was Q2. And indeed, if you compare the Q4 sensitivities, you will see that these are higher. For the majority of the change, it really is this DTA gap, which I should reiterate is not an economic effect. It's an effect caused by Solvency II Tiering rules.
There is also we had in Q3 an update of the VOLA reference portfolio, the volatility adjuster, and that is now less of a good match, if you like, with our portfolio. So that has also contributed a little bit to the increasing sensitivities that you see from Q2 to Q4. But apart from that, there's nothing else in there.
Okay.
And then Delfin on the growth in Japan Life.
Yes. Yes, indeed. For Japan Life, the impact on the when you focus on the quarter, I mean, in the quarter, in the Q4, basically, there is some drag because of the technical margin in Japan, and that is related to more negative mortality results and a lower surrender. Mortality results were worse than in the same quarter of last year, and there were some lower surrender results there. And I think that is the main element dragging the profitability in the quarter under IFRS.
I mean, our premium income has grown close to 30%, excluding currency impacts. All being equal, this will drive profit growth due to the corresponding growth in fee and premium revenues, based revenues as we move forward in the quarters to come.
Okay. Thank you.
The next question is from Mr. Darshan Mistry, Citi. Go ahead please.
Hi there. Thank you for taking my question. Firstly, just coming back to this lack DT issue. I was wondering whether you're able to see how much of your higher recoverability rates compared to some of your peers is due to the fact that you have a well capitalized group with a significant amount of free cash at the holding company. And whether, for example, if that were to change because of an acquisition or other use of that free capital at the holding company, would your ability to recover lack DT change?
So could we see a reduction in your recoverability rate? And the second one was on your on Polish pension fund reforms. I noticed some kind of news flow over the last week on updates to the kind of pension fund reform in Poland. So I was wondering if you could give us an update on your expectations and how that might evolve and what impact that might have on your European business?
Yes. Thank you very much, Darsan. So on LAC TD LAC DT, sorry, this is Delfin, and I will take the Polish one later. Thank you.
Darshend, yes, you're absolutely right. I mean, the two factors, the level at which you are capitalized as well as what is the prospects of capital generation of Terasciocas play a role. I think that our ability to use the LAC DT is driven by both. We should not underestimate also what is the capital generation capability of our different business, as you know, post shock, but no doubt with less capitalized situation to start with that might reduce in the future somehow the Laggediti the ability to recognize Laggedy going forward. But I wouldn't mention this as the main aspect now because the capacity to originate profits going forward is very significant.
Yes. And then, Darshend, on the Polish pension reform. There is indeed some recent news flow where the original ideas have now been endorsed by the government itself, and they need to bring their what they call the strategy for they call it themselves a responsible development. They need to bring that now to Parliament. So it's a little bit too early to comment on the exact effects that it will have because it will require discussion in Parliament and we need to await those consultations to have a final piece of legislation that we can that we know is going to be introduced.
So that's a bit too early. But in summary, it's not really possible at this moment to fully assess the impact on us given the fact that it still needs to go through Parliament. But if the proposal would be adopted in its current form, basically, as a short term, it may adversely impact the profitability of our Polish pension business. But longer term, it also leads to opportunities for the business structurally.
Okay. Thank you.
The next question is from Mr. Farooq Hanif, Credit Suisse. Go ahead please.
Hi there. Just two quick questions. On the SCR, you've alluded to the DB to DC trend in terms of renewals, which is a slow trend in terms of capital release. But how many years is it going to take, in your view, before we reach that wave and we start to see a more material reduction in NN Life SCR in the DB book? That's question 1.
Question 2 is what can you do to address the Tier 3 issue because it feels like it's only going to get bigger for you as time goes on and also could be a complication with the Del Floyd acquisition. So what can you do in terms of mix of capital that reduces that sensitivity and what actions are you taking? Thanks.
Yes. Thanks, Farooq. So first on the on your first question, it's going to that's I don't have a specific time line for you, but it's going to take long. As I said, the existing stock of defined benefit plans are on your balance sheet. The new money is oftentimes and most of the times renewed on a defined contribution basis.
But before that, let's say, defined contribution has completely overtaken the stock of defined benefit that's really going to take quite a while to materialize. So it's a slow movement, which we've always said it
would be a slow
movement on the balance sheet, but it's, of course, a market movement, which is quite pronounced and for which we are very well positioned. We have various rods in the pond, a good product line and a good business to capture that opportunity.
Now about the If I may quickly follow-up on that. Just I know you it's impossible and it's very actuarial, but are you basically saying, look, in the typical analyst, 3 years to 5 year time frame, don't factor this in at all?
I would certainly not think that you will see a massive change in the balance sheet in 3 to 5 years now. But you will see this trend, Farooq. So it's a trend, but it will be quite slow and gradual. About the composition of the capital, Delfin?
Yes. I think the question Farooq is about what we can do about the tiering. And somehow, as you know, the tiering works as it works and sometimes comes in your favor, sometimes comes a little bit against you. So clearly, this quarter with the reduction on the solvency capital requirement and as a consequence also with the reduction of the value of our fixed income securities, that has increased the deferred tax asset. And at the same time, the tiering cap as you know, has reduced.
I think that for Tier 3, there is not much to do. We'll always be limited to the 15% cap. Maybe, I don't know if Jacque Henri, you want to add something on this?
Yes. I think that's right, Delfin. Just to add one comment is that it's a funny dynamic because the one thing we can, of course, do is to increase our SCR by taking more risk, and then we would have more Tier 3 capacity. So it does increase the resilience a little bit if you think about that. But apart from that, we are bound by the rules.
So you won't consider taking more Tier 2 or other actions like that?
In terms of I mean, as you know, as from 1st January, we no longer have the restricted Tier 1 subordinated bonds from owned by ING Bank. So that has reduced our Tier 1 and we replaced that already with €850,000,000 of Tier 2. So we have already increased the tiering of Tier 2 and these ratios, of course, will be presented as part of Q1.
Okay. Thank you very much.
Next question is from Mr. Stephen Haywood, HSBC. Go ahead please.
Good morning everyone. Just two questions please. On the Non Life business, you still have the 97% combined ratio target for next year. Do you think this will be achieved? And then there was one of your peers flagged this morning about personal injury claims having had a substantial negative impact on their earnings due to changes in laws and regulations.
Could you describe what's going on here and if you're seeing similar changes as well? And then second question on the ING Life Korea provision, are we to assume this is around a €60,000,000 impact here? Thank you.
Yes. So first, Delfin, maybe you can do the ING Life Korea and then I'll get back to you, Stephen, on Non Life points.
Yes. On NN Life Korea, we have not disclosed any amount, and we have done that on purpose because there is still some negotiations as we speak, and therefore, we consider that to be commercially sensitive. The result of both Korea and the transfer of the NNREL Ireland portfolio are reflected in the line of results from divestments?
Yes. On your first two questions, Stephen, we keep our commitment to work towards the 97% combined ratio, but obviously recognize that we need to do more work to get it to reach it. Where it pertains to your other point on personal injury, I can't comment on the lesser results of peers. Obviously, Personal injury is not significant for us.
Okay. Thank you very much.
Next question is from Mr. Darshan Mistry. Go
A couple of follow-up questions, please. Firstly, you're going to be taking if the Delta Lloyd acquisition goes through, you're going to be taking on a lot of longevity risk. So are you considering the use of longevity swaps or longevity reinsurance? And if so, can we expect a material capital benefit from doing so? That was one question.
And the second question is your Solvency II sensitivity is they obviously still remain quite volatile. In the event of you lowering your capital ratio being lowered to around the 180, 185 level, could we expect you to take some sort of actions and some changes in your hedging policies to reduce that volatility? Thank you.
Thanks, Darshan. Sian Hendrik?
Thank you, Darshan, for those questions. Yes, you are right that we will be increasing after the transaction and if it completes as planned, our exposure to Dutch longevity risk. And we are, of course, preparing for many scenarios, and we have been investigating for several years the opportunity to offload some of that risk when it makes sense for us. At this stage, I think it looks relatively promising if you look at the market that you can get capital relief from those levers. But of course, it's premature to speculate today on exactly what we will do after a transaction that we have not yet completed, etcetera, etcetera.
On your second point, it's a little bit the same. I mean, we have not yet completed this transaction. The latest pro form a Q3 guidance that we gave on the 23rd December. So again, we will have to consider our sensitivities very carefully after the transaction is completed. We are aware of many things we can do with our balance sheet, and we are always preparing for different scenarios, but it's premature to speculate.
Thank you very much.
Next question is from Mr. Stephen Haywood, HSBC. Go ahead
please. Just another question, more cases of what you plan to do in the future. Your €2,500,000,000 of cash at holding, if you take away the final dividend and the cash costs that acquisition does, you get to about €800,000,000 But then if your free cash flow in 2017 is again €1,300,000,000 or high, you get to over EUR 2,000,000,000 minus an interim dividend, just still around the EUR 2,000,000,000 level. What is your plan? Because you're going to be considerably above your sort of maximum excess capital position for holding company target by the end of this year.
Can you talk about any plans for future capital repatriation again? Or is it wait and see time?
Yes, Delfin?
Yes. Thank you, Stefan. So basically, with the acquisition of Delta Lloyd, we're not intending to change our capital management or dividend approach. So we will continue be applying the same approach of if there is to assist any surplus capital to repay back to shareholders in the most efficient manner, share buybacks being, of course, one of the alternatives that come very high on mind. However, I think at this point of time, it will be a bit premature to start speculating when and how that will take place.
We still are hoping, expected to complete the transaction by mid April. That will put EUR 2,500,000,000 of surplus of a part of the surplus capital at play. And from there, we'll have to see how the cash capital at holding develops. But the key message here is no change of the capital management and dividend policy as we have explained in the past.
Okay. Many thank you.
Operator, are we yes? So I think there's no further questions.
There's one additional coming up.
Okay. Thank you very much.
At the last minute, that's Mr. Ashik Musaddi, JPMorgan. Yes. Hi. Sorry, just one follow-up.
Can you give us some indication about what are the mean, how much more re risking possibility is there in your current NN book? I mean, are you looking to do continue to do a bit more? Or you think that current asset profile is more or less the same? And just including that, I mean, any thoughts about your European operations? How should we think about growth in that growth in earnings from European operations?
Thank you.
Yes. So Ashik, first, I'll the first question will be covered by Delfin. The second one, I'll give you some views on the Insurance Europe.
Yes, 16, we basically allocated approximately EUR 4,500,000,000 into these higher yielding assets. As I have explained in the past, this very much a question of availability of the fixed income securities or the assets that fit within our ALM approach, but we will gradually continue with the same approach that we have done so far. And there is still room not only for mortgages, but also other assets in order to continue that journey that is gradual, has not been in one go or very drastic any quarter, but you could expect the most likely evolution following that same pattern.
Yes, and Ashik, and when it comes to Europe, you know that at the time of the IPO, we set ourselves a target there, which is a mid single digit on average earnings growth target for Europe. Obviously, that is a target that we maintain and we continue to drive towards. And if I look what the business there has been doing, it's really markedly changed its product mix away from guaranteed products to spread and not so to fee, but from strong spread to fee products and protection, which I think has gone quite well. Building out distribution through organically, but also inorganically by buying, for instance, the broker in Poland. So that's our target.
That's what we're going to work towards. At the same time, we keep the expenses under control and that's what you basically see happening in Europe. I think with that, I think it's time to conclude the call. I want to thank you very much for all your questions. Let me conclude by saying that our priority remains to improve the operating performance of our businesses, to increase earnings and generate cash.
We're making good progress, but we still have more work to do to achieve all the targets that we have set ourselves. And looking forward, we will never lose sight of our main purpose and it is to help our customers to secure their financial futures. I want to thank you for all your questions, your time and your attention, and I wish you a very good day.
This concludes the NN Group analyst call. Thank you for attending and you may disconnect your line now.